# A 24 Month Study, to Compare the Efficacy of Doxycycline vs. Placebo for Improving Filarial Lymphedema in Mali

> **NCT02927496** · PHASE3 · COMPLETED · sponsor: **The Task Force for Global Health** · enrollment: 220 (actual)

## Conditions studied

- Lymphedema
- Lymphatic Filariasis
- Filariasis

## Interventions

- **DRUG:** Doxycycline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02927496
- **Lead sponsor:** The Task Force for Global Health
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-19
- **Primary completion:** 2020-12-19
- **Final completion:** 2020-12-19
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2021-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02927496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02927496, "A 24 Month Study, to Compare the Efficacy of Doxycycline vs. Placebo for Improving Filarial Lymphedema in Mali". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02927496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*